The “Pill-in-the-Pocket” Approach to Atrial Fibrillation

The “Pill-in-the-Pocket” Approach to Atrial Fibrillation

To the Editor: Alboni and colleagues (Dec. 2 issue) 1 present data from a prospective study investigating the strategy of rhythm control in patients with paroxysmal atrial fibrillation by self-administration of antiarrhythmic agents (the “pill-in-the-pocket” approach). According to the inclusion cri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2005-03, Vol.352 (11), p.1150-1151
Hauptverfasser: Grönefeld, Gerian C, Hohnloser, Stefan H
Format: Artikel
Sprache:eng
Schlagworte:
Anti-Arrhythmia Agents - therapeutic use
Atrial Fibrillation - drug therapy
Fibrinolytic Agents - therapeutic use
Humans
Risk Factors
Stroke - prevention & control
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1151
container_issue 11
container_start_page 1150
container_title The New England journal of medicine
container_volume 352
creator Grönefeld, Gerian C
Hohnloser, Stefan H
description To the Editor: Alboni and colleagues (Dec. 2 issue) 1 present data from a prospective study investigating the strategy of rhythm control in patients with paroxysmal atrial fibrillation by self-administration of antiarrhythmic agents (the “pill-in-the-pocket” approach). According to the inclusion criteria, patients 18 to 75 years old were recruited, with 44 percent of the study population having some structural heart disease. Therefore, some of these patients were likely to have had risk factors for stroke and should have received antithrombotic therapy, which is considered a cornerstone of treatment for atrial fibrillation. 2 – 4 Accordingly, the authors should provide additional information on the . . .
doi_str_mv 10.1056/NEJM200503173521119
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67542555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67538961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-112f85e851e0a5062608819baf3482654bf499d79b7a71b2cec52bc55d9972493</originalsourceid><addsrcrecordid>eNqNkMtKAzEYhYMotlafQJBZuZFo_twDbkppveCli7oeMmmGTp3p1Ml04a4Poi_XJzHSghsR_82Bn-8cDgehUyCXQIS8ehreP1JCBGGgmKAAYPZQFwRjmHMi91GXEKoxV4Z10FEIcxIPuDlEHRBKc6mgi64nM59s1h_joixxscDtzONx7V59u1l_Jv3lsqmtmyVtnfTbprBlMiqyJrK2LerFMTrIbRn8yU576GU0nAxu8cPzzd2g_4CdILLFADTXwmsBntj4oZJoDSazOeOaSsGznBszVSZTVkFGnXeCZk6IqTGKcsN66HybG9u8rXxo06oIzscWC1-vQiqV4FQI8R-QaSMhgmwLuqYOofF5umyKyjbvKZD0e930l3Wj62wXv8oqP_3x7OaMwMUWqKqQLvy8-jPuC8WLgDM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67538961</pqid></control><display><type>article</type><title>The “Pill-in-the-Pocket” Approach to Atrial Fibrillation</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Grönefeld, Gerian C ; Hohnloser, Stefan H</creator><creatorcontrib>Grönefeld, Gerian C ; Hohnloser, Stefan H</creatorcontrib><description>To the Editor: Alboni and colleagues (Dec. 2 issue) 1 present data from a prospective study investigating the strategy of rhythm control in patients with paroxysmal atrial fibrillation by self-administration of antiarrhythmic agents (the “pill-in-the-pocket” approach). According to the inclusion criteria, patients 18 to 75 years old were recruited, with 44 percent of the study population having some structural heart disease. Therefore, some of these patients were likely to have had risk factors for stroke and should have received antithrombotic therapy, which is considered a cornerstone of treatment for atrial fibrillation. 2 – 4 Accordingly, the authors should provide additional information on the . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM200503173521119</identifier><identifier>PMID: 15784671</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Anti-Arrhythmia Agents - therapeutic use ; Atrial Fibrillation - drug therapy ; Fibrinolytic Agents - therapeutic use ; Humans ; Risk Factors ; Stroke - prevention &amp; control</subject><ispartof>The New England journal of medicine, 2005-03, Vol.352 (11), p.1150-1151</ispartof><rights>Copyright © 2005 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-112f85e851e0a5062608819baf3482654bf499d79b7a71b2cec52bc55d9972493</citedby><cites>FETCH-LOGICAL-c506t-112f85e851e0a5062608819baf3482654bf499d79b7a71b2cec52bc55d9972493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM200503173521119$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJM200503173521119$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2745,2746,26082,27903,27904,52360,54042,64363</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15784671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grönefeld, Gerian C</creatorcontrib><creatorcontrib>Hohnloser, Stefan H</creatorcontrib><title>The “Pill-in-the-Pocket” Approach to Atrial Fibrillation</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor: Alboni and colleagues (Dec. 2 issue) 1 present data from a prospective study investigating the strategy of rhythm control in patients with paroxysmal atrial fibrillation by self-administration of antiarrhythmic agents (the “pill-in-the-pocket” approach). According to the inclusion criteria, patients 18 to 75 years old were recruited, with 44 percent of the study population having some structural heart disease. Therefore, some of these patients were likely to have had risk factors for stroke and should have received antithrombotic therapy, which is considered a cornerstone of treatment for atrial fibrillation. 2 – 4 Accordingly, the authors should provide additional information on the . . .</description><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Atrial Fibrillation - drug therapy</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Humans</subject><subject>Risk Factors</subject><subject>Stroke - prevention &amp; control</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtKAzEYhYMotlafQJBZuZFo_twDbkppveCli7oeMmmGTp3p1Ml04a4Poi_XJzHSghsR_82Bn-8cDgehUyCXQIS8ehreP1JCBGGgmKAAYPZQFwRjmHMi91GXEKoxV4Z10FEIcxIPuDlEHRBKc6mgi64nM59s1h_joixxscDtzONx7V59u1l_Jv3lsqmtmyVtnfTbprBlMiqyJrK2LerFMTrIbRn8yU576GU0nAxu8cPzzd2g_4CdILLFADTXwmsBntj4oZJoDSazOeOaSsGznBszVSZTVkFGnXeCZk6IqTGKcsN66HybG9u8rXxo06oIzscWC1-vQiqV4FQI8R-QaSMhgmwLuqYOofF5umyKyjbvKZD0e930l3Wj62wXv8oqP_3x7OaMwMUWqKqQLvy8-jPuC8WLgDM</recordid><startdate>20050317</startdate><enddate>20050317</enddate><creator>Grönefeld, Gerian C</creator><creator>Hohnloser, Stefan H</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050317</creationdate><title>The “Pill-in-the-Pocket” Approach to Atrial Fibrillation</title><author>Grönefeld, Gerian C ; Hohnloser, Stefan H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-112f85e851e0a5062608819baf3482654bf499d79b7a71b2cec52bc55d9972493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Atrial Fibrillation - drug therapy</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Humans</topic><topic>Risk Factors</topic><topic>Stroke - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grönefeld, Gerian C</creatorcontrib><creatorcontrib>Hohnloser, Stefan H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grönefeld, Gerian C</au><au>Hohnloser, Stefan H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The “Pill-in-the-Pocket” Approach to Atrial Fibrillation</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2005-03-17</date><risdate>2005</risdate><volume>352</volume><issue>11</issue><spage>1150</spage><epage>1151</epage><pages>1150-1151</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor: Alboni and colleagues (Dec. 2 issue) 1 present data from a prospective study investigating the strategy of rhythm control in patients with paroxysmal atrial fibrillation by self-administration of antiarrhythmic agents (the “pill-in-the-pocket” approach). According to the inclusion criteria, patients 18 to 75 years old were recruited, with 44 percent of the study population having some structural heart disease. Therefore, some of these patients were likely to have had risk factors for stroke and should have received antithrombotic therapy, which is considered a cornerstone of treatment for atrial fibrillation. 2 – 4 Accordingly, the authors should provide additional information on the . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>15784671</pmid><doi>10.1056/NEJM200503173521119</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2005-03, Vol.352 (11), p.1150-1151
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_67542555
source MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine
subjects Anti-Arrhythmia Agents - therapeutic use
Atrial Fibrillation - drug therapy
Fibrinolytic Agents - therapeutic use
Humans
Risk Factors
Stroke - prevention & control
title The “Pill-in-the-Pocket” Approach to Atrial Fibrillation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T11%3A48%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20%E2%80%9CPill-in-the-Pocket%E2%80%9D%20Approach%20to%20Atrial%20Fibrillation&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Gr%C3%B6nefeld,%20Gerian%20C&rft.date=2005-03-17&rft.volume=352&rft.issue=11&rft.spage=1150&rft.epage=1151&rft.pages=1150-1151&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM200503173521119&rft_dat=%3Cproquest_cross%3E67538961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67538961&rft_id=info:pmid/15784671&rfr_iscdi=true